Navigating the new era of B2B sales

Heightened budget pressure, increasing competitions and ongoing fine-tuning of the value rating system: NRDL gets tougher this year.2024 NRDL has been unfolding very much as planned: A total of 574 drug candidates went into the National Reimbursement Drug List (NRDL) formal review process in June, and 445 of them passed the formal review in August, a record high since 2021. Among those, 249 are se